Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Eyepoint Pharmaceuticals Inc (EYPT)

Healthcare Biotechnology
12.30 $
-4.7% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Eyepoint Pharmaceuticals Inc (EYPT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 84.1% of the shares are freely tradable; institutional investors hold 111.8%.

Ownership Structure

Institutional ownership
111.8%
Insiders
3.7%
Float
84.1%
Short % of float
19.0%
Shares Outstanding
84Mio.

Largest Shareholders

Institutions

Institutions EYPT
Name Stake (%) Shares Change (%) Date
Suvretta Capital Management, LLC 9.90 8,296,375 +6.0 03/31/2026
Cormorant Asset Management, LLC 9.86 8,265,000 +0.0 03/31/2026
BlackRock Inc 8.56 7,177,337 +5.7 03/31/2026
Federated Hermes Inc 6.76 5,669,589 -5.8 03/31/2026
Franklin Resources Inc 6.02 5,048,598 +1.4 03/31/2026
Vanguard Group Inc 5.75 4,822,139 +27.1 12/31/2025
HHG PLC 4.30 3,601,168 +22.6 03/31/2026
Vanguard Capital Management, LLC 4.25 3,559,569 +0.0 03/31/2026
Adage Capital Partners Gp LLC 3.94 3,300,000 -29.8 03/31/2026
Paradigm Biocapital Advisors LP 3.75 3,142,437 -14.9 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
10. Jul 2026 Duker Jay S. President and CEO Other 8,059 14.72 118,628
10. Jul 2026 Duker Jay S. President and CEO Other 16,667 0.00
17. Apr 2026 Ramiro Ribeiro Insider Sell 2,437 15.00 36,555

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?